United Kingdom
Alnylam (Consultant/Advisory Board)Pfizer (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support, Educational grant)
Perry Elliott (H-index 109) is Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR). He is Director of the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at the Bart’s Heart Centre, St. Bartholomew's Hospital London, UK. He is Chairman of the ESC Heart Academy and the ESC Council on Cardiovascular Genomics, past Chairman of the ESC Working Group on Myocardial and Pericardial Diseases (2010–2012), the Executive Committee for the European Outcomes Research Programme registry on cardiomyopathies, and the 2014 ESC Guideline Task Force on Hypertrophic Cardiomyopathy. He is a member of the ESC Congress Programme Committee of the ESC Heart Agency. He is cardiovascular lead for the North Thames NHS Genomic Medicine Centre and President of Cardiomyopathy UK, Europe’s foremost charity for patients with heart muscle disease. He is currently an executive Editor for the European Heart Journal.
Over the past 30 years, Prof. Elliott has established an international reputation in the field of heart muscle disease, authoring more than 500 peer-reviewed papers on the subject. He develops diagnostic standards, risk stratification tools and clinical service models based on some of Europe’s largest inherited heart disease cohorts, fostering industry collaborations in sequence interpretation, therapeutic trials and multicentre research partnerships.